Navigation Links
Epileptic Drug Found To Be Efficient As A Single Therapy

A study conducted by the scientists at Western Infirmary Epilepsy Unit in Glasgow, //confirmed that drug levetiracetam is effective as a single therapy. This study was published in the journal Neurology.

This was a double-blind study which had around six hundred participants who had suffered at least two attacks of convulsions in the last year to the drug levetiracetam or to controlled release carbamazepine which is considered as the usual therapy for epilepsy.

Generally levetiracetam is used in combination with other drugs. But this is the first time it was tested as a lone therapy. It was found that 72.8% of people who had received carbamazepine did not have epileptic attack for six months while it was 73% for levetiracetam users.

Dr Martin Brodie who is the lead scientist of this study opines that levetiracetam has an edge over other epileptic drugs as it is proved to be a safe and user friendly drug. This study also emphasizes the fact that epileptic patients react better to the drug that is given to them first at low dosage levels.


JYT
'"/>




Page: 1

Related medicine news :

1. Epileptic Seizures Can Be Due to Heart Problem
2. Epileptic Drug Found To Be Effective In Relieving Headache
3. Brain Septum Could Help In reducing Epileptic Seizures
4. Father Who Killed Epileptic Son Says He Misses Him
5. Simple Act of Brushing Your Teeth can Trigger an Epileptic Fit, Say Experts
6. Light-activated Compound May Be of Help for Epileptics in Future
7. Anti-Epileptic Drug Intake May Result In Children With Mental Retardation
8. Fluoride Found Effective in Osteoporosis
9. Implantable Contact Lens Found Safe and Effective
10. Cancer hazard Found With Animal-Based Nutrients
11. Processed Meat, Diabetes connection Found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/1/2016)... Aliso Viejo, CA (PRWEB) , ... May 01, 2016 , ... ProBrand Reveal Volume 2 ... Pro X . With ProBrand Reveal Volume 2 keyframeless animations, users can easily create a ... over the look and feel of the various presets. Use these title presets to add ...
(Date:5/1/2016)... CA (PRWEB) , ... May 01, 2016 , ... Good ... those in need of chiropractic help. The agency offers a verity of health, life ... chiropractic need. According to Chris Nelson at the firm, “Many insurance plans don’t cover ...
(Date:4/30/2016)... , ... April 30, 2016 , ... ... Studios. With inMotion3D Abstract users can distort and manipulate three-dimensional shapes with ease ... rotation, columns, rows, ranks, point, lines, polygons, polygon texture animation, opacity texture animation, ...
(Date:4/30/2016)... (PRWEB) , ... April 30, 2016 , ... ... today announced RANKED Health , a program to critically evaluate and rank ... goal of the program is to provide independent, unbiased and accurate information to ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... President and CEO of EMED, today signed a multifaceted agreement which will allow ... the Northern Caribbean University Department of Natural and Applied Sciences, Allied Health and ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016  While Abbott,s announced purchase of St. ... repair and stent business, healthcare research firm Kalorama ... firmly into patient monitoring.  Kalorama said that patient ... areas, with double-digit growth expected the next 5 ... Remote Patient Monitoring . Abbott Laboratories agreed ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
Breaking Medicine Technology: